Express Pharma - Express Pharma

Takeda’s dengue vaccine candidate was generally well-tolerated, and no important safety risks have been observed to date

Product to be relaunched with immediate effect

Incident of counterfeit cases in India have increased by nearly 15 per cent in 2019. Currency, Liquor, FMCG (F&B) and pharma…

Organised for the first time in India, the event witnessed and welcomed regulatory bodies, international organisations and more…

Ranjit Barshikar, QbD/cGMP consultant; Quality Expert - Consulting at United Nations MPP projects and member of Editorial Board of…

The company had posted net profit of Rs 288.45 crore in July-September period of 2018-19

This gives time to the maker of OxyContin time to try to reach legal settlement the company says is worth $10 billion

Kamal Dutta, MD India for Skillsoft writes about the perks of investing in up-skilling and retraining programmes for employees by…

The portfolio, which Takeda is selling in a push to slash debt after its $59 billion purchase of Shire, includes drugs sold…

Dr Ge Li wins ‘CEO of the year’ and John Chiminski a ‘lifetime achievement award’, with 11 further outstanding winners unveiled